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Protocol
AbstrACt
Introduction Flexible intensive care unit (ICU) visiting 
hours have been proposed as a means to improve 
patient-centred and family-centred care. However, 
randomised trials evaluating the effects of flexible family 
visitation models (FFVMs) are scarce. This study aims to 
compare the effectiveness and safety of an FFVM versus 
a restrictive family visitation model (RFVM) on delirium 
prevention among ICU patients, as well as to analyse its 
potential effects on family members and ICU professionals.
Methods and analysis A cluster-randomised crossover 
trial involving adult ICU patients, family members and ICU 
professionals will be conducted. Forty medical-surgical 
Brazilian ICUs with RFVMs (<4.5 hours/day) will be randomly 
assigned to either an RFVM (visits according to local policies) 
or an FFVM (visitation during 12 consecutive hours per 
day) group at a 1:1 ratio. After enrolment and follow-up of 
25 patients, each ICU will be switched over to the other 
visitation model, until 25 more patients per site are enrolled 
and followed. The primary outcome will be the cumulative 
incidence of delirium among ICU patients, measured twice 
a day using the Confusion Assessment Method for the ICU. 
Secondary outcome measures will include daily hazard of 
delirium, ventilator-free days, any ICU-acquired infections, 
ICU length of stay and hospital mortality among the patients; 
symptoms of anxiety and depression and satisfaction among 
the family members; and prevalence of burnout symptoms 
among the ICU professionals. Tertiary outcomes will include 
need for antipsychotic agents and/or mechanical restraints, 
coma-free days, unplanned loss of invasive devices and ICU-
acquired pneumonia, urinary tract infection or bloodstream 
strengths and limitations of this study
 ► The present study is the first large-scale trial aimed 
to evaluate the effects of different intensive care unit 
(ICU) visiting policies on relevant outcomes among 
patients, family members and ICU professionals.
 ► This study is designed as a cluster-randomised 
crossover trial, which reduces the risk of contami-
nation and improves covariate balance between the 
two study arms and statistical efficiency.
 ► This study uses strategies to enhance the imple-
mentation and evaluation of complex interventions 
such as some degree of adaptability to local cir-
cumstances, a learning period to study interven-
tions and assessment of fidelity and quality of the 
implementations.
 ► The infeasibility of blinding patients, family mem-
bers and ICU professionals to the study interventions 
is a limitation.
 ► The results of this study will allow healthcare pro-
fessionals, researchers and policymakers to draw 
conclusions about the efficacy and safety of a flex-
ible family visitation model for delirium prevention 
in adult ICUs.
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infection among the patients; self-perception of involvement in patient care 
among the family members; and satisfaction among the ICU professionals.
Ethics and dissemination The study protocol has been approved by 
the research ethics committee of all participant institutions. We aim to 
disseminate the findings through conferences and peer-reviewed journals.
trial registration NCT02932358.
IntroduCtIon
Adult intensive care unit (ICU) visitation policies vary 
worldwide; generally, patients admitted to the ICU are 
only allowed visitors during certain periods of the day.1–3 
Congruent with this scenario, most Brazilian ICUs have 
a restrictive policy of family visits in which visiting hours 
typically last from 30 min to 1 hour, two to three times a 
day.4 These restrictive ICU visit policies are rooted mainly 
in a theoretical increased risk of physiological stress, 
infectious complications and disorganisation of care.5 
However, these theoretical risks have not been consis-
tently confirmed by the scarce literature on this subject,6–9 
and flexible ICU visiting hours have been proposed as a 
means to improve outcomes through patient-centred and 
family-centred care and delirium prevention.10–12 
Evidence from small observational and before-and-after 
studies suggests that flexible ICU visitation policies are 
associated with higher satisfaction among patients and 
patients’ families and with reduction of patient stress.13 14 
Accordingly, one pilot randomised trial showed reduction 
in cardiocirculatory complications among ICU patients 
admitted during periods of unrestricted visiting hours, 
possibly due to reduction of anxiety and establishment 
of a more favourable hormonal profile.6 Moreover, some 
studies suggest the potential role of presence of family 
members as a strategy to prevent ICU delirium.15–17 One 
small prospective single-centre before-and-after study 
found a reduction of 50% in the cumulative incidence 
of delirium by changing the visitation policy from a 
restrictive model (4.5 hours/day) to an extended model 
(12 hours/day); the length of delirium and ICU stay was 
also reduced in this study.12 In this regard, the presence 
of family in the critical care setting is suggested as a means 
to achieve better pain control, reduce the use of sedatives 
and participate in the reorientation and cognitive stim-
ulation of patients. These benefits have been associated 
with lower incidence of delirium in studies evaluating 
multicomponent non-pharmacological interventions to 
prevent delirium and constitute the rationale for the F 
(Family Engagement and Empowerment) component 
of the ABCDEF bundle, an evidence-based approach to 
prevent delirium.18–21
Regarding possible risks associated with flexible 
ICU visit policies, some studies have shown that ICU 
professionals sometimes perceive visits as a source of 
increased workload and disorganisation in patient care, 
instead of considering families as ‘one’ with the patient 
and as potential sources of reassurance and comfort.22 23 
In a single-centre study,23 59% of ICU staff members stated 
that the open visitation policy impaired the organisation 
of patient care, and 72% believed that their work suffered 
more interruptions due to the extended presence of fami-
lies in the ICU. Congruent with these data, one before-
and-after study with nine ICUs8 showed a significant 
increase in burnout levels among ICU professionals after 
a partial liberalisation of visiting policies. The impact 
of educational strategies directed to ICU visitors in the 
context of flexible family visitation policies to prevent 
disorganisation of patient care and burnout among ICU 
professionals is not known. In relation to the risk of infec-
tion, this topic has been evaluated by few underpowered 
studies.7 12 15 Although one study15 showed greater envi-
ronmental microbial contamination during an open 
policy of ICU visitation, published studies7 12 15 failed to 
show an association between flexible ICU visiting hours 
and nosocomial infection. Lastly, the impact of flexible 
ICU visiting hours on symptoms of anxiety and depression 
of family members is not well studied: there is plausibility 
for decreased anxiety and depression with flexible ICU 
visiting hours as a result of improved access to informa-
tion and more effective sharing of the decision-making 
process24; conversely, it is also plausible to assume that 
anxiety and depression will increase as a result of higher 
exposure of family members to complex situations such 
as terminality and the patient’s emotional and physical 
suffering.25 26
The implementation of a flexible family ICU visitation 
policy, although promising due to its low cost and poten-
tial to improve quality of care, is a complex organisational 
process, given that multiple populations involved in this 
context may be affected by the intervention in different 
ways. Additionally, most evidence regarding this inter-
vention is originated from underpowered observational 
and before-and-after studies. Specifically, no large-scale 
randomised trial so far has evaluated the potential impact 
of different ICU visitation models on patient, family 
and ICU staff outcomes. We hypothesise that compared 
with the restrictive family visitation model (RFVM), a 
flexible family visitation model (FFVM) supported by 
visitor education will reduce the cumulative incidence of 
delirium among adult ICU patients, reduce symptoms of 
anxiety and depression and increase satisfaction with care 




The aim of the present study is to assess if an FFVM, 
compared with an RFVM, can prevent delirium in adult 
ICU patients.
secondary objectives
Our secondary objective is to compare the efficacy and 
safety of both ICU visitation models with regard to three sets 
of variables: ICU/patient-related variables (daily hazard 
of delirium, ventilator-free days, ICU-acquired infections, 
ICU length of stay, all-cause hospital mortality, need for 
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antipsychotic use, coma-free days, need for mechanical 
restraints and unplanned loss of invasive devices), fami-
ly-related variables (symptoms of anxiety and depression, 
satisfaction and self-perception of involvement in patient 
care) and ICU staff variables (prevalence of symptoms of 
burnout syndrome and satisfaction).
MEthods
The present study protocol follows the Standard Protocol 
Items: Recommendations for Interventional Trials state-
ment recommendations.27 The items from the WHO trial 
registration data set are described in online supplemen-
tary file 1. This study protocol was registered at  Clinical-
trials. gov before the randomisation of the first cluster 
(NCT02932358) .
study design
The present study was designed to be a cluster-ran-
domised, crossover trial involving mixed medical-sur-
gical ICUs. In this study, the unit of randomisation 
is the ICU, since the proposed intervention involves 
components at the organisational level and is intended 
to be implemented in the whole ICU and not for 
selected patients. All ICUs will receive both FFVM 
and RFVM, and the randomisation will determine in 
which order the visitation models will be evaluated in 
each ICU (figure 1). The initial intervention (phase 1) 
will involve ICU randomisation to either an FFVM or 
an RFVM. In phase 2, each ICU will be crossed over 
to the other visitation model. The study analysis will be 
performed at the subject level according to the inten-
tion-to-treat principle and accounts for the cluster-ran-
domised crossover design.
Participants
Cluster eligibility, recruitment and exclusion criteria
Brazilian adult ICUs of public and philanthropic hospi-
tals will be invited to participate in the trial. Mixed medi-
cal-surgical ICUs with at least six beds and a restrictive 
policy of family visitation (<4.5 hours/day) are consid-
ered eligible. ICUs with structural or organisational 
impediments to flexible family visitation, according to the 
Brazilian resolution of minimal operational requirements 
for ICUs,28 will be excluded.
Patient eligibility, recruitment and exclusion criteria
Consecutive patients aged ≥18 years admitted to the ICU 
during phases 1 and 2 will be enrolled in each cluster. 
Subjects in a coma (Richmond Agitation Sedation Scale 
(RASS)29 −4 or −5) lasting >96 hours from the moment of 
first evaluation for recruitment and those with delirium at 
baseline (positive Confusion Assessment Method for ICU 
(CAM-ICU)30) will be excluded. The following exclusion 
Figure 1 Study design. During the study, the ICU intervention (FFVM or RFVM) will be applied to all admitted patients apart 
of meeting inclusion criteria for the study. The length of study phases in each ICU will be determined by the patient recruitment 
rate (25 patients in phase 1 and 25 patients in phase 2). Patients and family members will be recruited during phases 1 and 
2. ICU professionals will be evaluated and followed up only during the phase 1. Following the recruitment of the 25th patient, 
during phase 1, a 30-day period without subject recruitment will occur to allow appropriate conclusion of the follow-up of all 
recruited patients for the study outcomes and to avoid contamination of the two study arms. FFVM, flexible family visitation 
model; ICUs, intensive care units; RFVM, restrictive family visitation model.  
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criteria will also be applied: cerebral death, aphasia, severe 
hearing deficit, predicted ICU length of stay <48 hours, 
exclusive palliative treatment at ICU admission, unavail-
ability of a family member to participate in the flexible 
family visits, unlikelihood to survive >24 hours, prisoner 
status and, lastly, readmission to the ICU after enrolment 
in the study.
Family member eligibility, recruitment and exclusion criteria
The sample of family members will include one family 
member per patient enrolled into the study, with the 
closest family member being selected. Family members 
who do not speak Portuguese or have serious impediment 
in answering the self-applied questionnaires (eg, illiteracy 
or severe visual or hearing limitations) will be excluded.
ICU professionals’ eligibility, recruitment and exclusion criteria
All bedside ICU professionals (physicians, nurses, nursing 
technicians and physiotherapists) of each cluster who 
assist patients during the daytime for at least 20 hours 
per week will be enrolled. ICU professionals who have a 
planned leave of absence of >15 days during phase 1 will 
be excluded.
Interventions
The proposed study interventions may be classified 
as complex because31: (A) there is a large number of 
interacting components within the experimental and 
control interventions (eg, changes in ICU processes, 
education of family members and engagement and 
training of the ICU multidisciplinary team); (B) there 
are several groups targeted by the intervention (ICU 
patients, family members and ICU professionals); 
(C) there is a large number and high variability of 
outcomes (evaluation of different outcome domains 
in three different target populations); (D) a limited 
degree of flexibility in the intervention is allowed 
(educational components may be tailored consid-
ering the educational level of the target population, 
visit hours may be customised according to internal 
processes of the ICU and expected acceptability of the 
target population).
Table 1 Components of study interventions
RFVM FFVM
Social visits X X
  Friends and family members allowed (number of simultaneous visitors allowed in patient’s room tailored 
to ICU preferences)
  Max 4.5 hours per day (according to ICU policies prior to randomisation)
Family visits X
  Up to two family members allowed (number of simultaneous visitors allowed in patient’s room tailored to 
ICU preferences)
  Maximum of 12 hours per day
  Family members must attend a structured information meeting
Information meeting X
  For family members who want to participate in the family visits
  Guidance about ICU environment, multidisciplinary work at ICU, common ICU treatments, palliative care, 
infection control practices, delirium prevention and rehabilitation
  Meeting conducted by a trained healthcare professional that works in the ICU (at least 3x/week)
  Both printed and digital material offered by the study coordinator site (tailored for the specific ICU 
preferences)
Printed material focused on patient safety during ICU visits X X
  Brochure with information about what is allowed and what is not allowed in a social visit
Printed material focused on education about ICU environment, practices and family engagement on patient 
care
X
  Brochure with information about ICU environment, multidisciplinary work at ICU, common ICU 
treatments, palliative care, infection control practices, delirium prevention, rehabilitation and family 
engagement on patient care
Access to a website focused on education about ICU environment, practices and family engagement on 
patient care
X
  Website with information about ICU environment, multidisciplinary work at ICU, common ICU treatments, 
palliative care, infection control practices, delirium prevention, rehabilitation and family engagement on 
patient care
FFVM, flexible family visitation model; ICU, intensive care unit; RFVM, restrictive family visitation model.
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We tested the feasibility and acceptability of imple-
mentation of the intervention in a single-centre before-
and-after study.12Table 1 shows the components to be 
implemented during FFVM and RFVM. During both 
FFVM and RFVM, all visitors will be required to perform 
hand hygiene by washing their hands with antiseptic soap 
or using alcohol-based hand-rub formulations and to wear 
disposable vests and/or personal protective equipment 
when appropriate (eg, contact or droplet precautions). 
All visitors will receive oral and written guidance about 
the minimum requirements to promote a safe and restful 
environment to ICU patients. The visitors will be asked 
to leave the room during some procedures such as intu-
bation, central venous or urinary catheterisation, bron-
choscopy, electrical cardioversion and cardiopulmonary 
resuscitation. As an exception, some patients, during both 
study interventions, will be allowed to receive visits longer 
than the maximum limit of visiting hours. This decision 
will be allowed in the following situations: patient age ≥65 
years, terminal illness and conflicts among patients or 
family and ICU staff.
Flexible family visitation model
In the FFVM, two or fewer close family members will 
be allowed to visit the patient for up to 12 consecutive 
hours each day. Family members who agree to join the 
family visits will have to attend a structured meeting at 
the ICU in which they will receive guidance about the 
ICU environment, common ICU treatments, rehabili-
tation and basic infection control practices, multidisci-
plinary work at the ICU and information on palliative 
care and delirium prevention. Additionally, family 
members will receive an information brochure and be 
encouraged to access a website (www. utivisitas. com. 
br), both of which are designed to explain, in simple 
terms, what happens during and after an ICU stay to 
legitimise emotions and improve cooperation with rela-
tives without increasing the ICU staff workload. In addi-
tion to family visitation, patients in the FFVM will be 
allowed to receive social visits at specific time intervals 
(according to the local ICU policies). Social visits will 
be offered to patient’s friends or other family members 
who did not qualify for family visitation. The number 
and duration of social visits will be determined by the 
patient or proxies. Social visitors will not be required to 
attend the structured meeting.
Restrictive family visitation model
In the RFVM, patients will be allowed visitors according 
to routine ICU practices but limited to the maximum of 
4.5 hour of visitation per day. Visitors will not be required 
to attend the structured meeting, because this is the stan-
dard of care in Brazil. The length of ICU visiting hours 
will be similar to that of social visits in the FFVM. The 
number and duration of visits will be determined by the 
patient or proxies taking into the account the limits of 
visiting hours dictated by local policies.
randomisation
The randomisation unit is the ICU. In hospitals where 
there is more than one ICU, each ICU will be considered 
a distinct randomisation units as long as the ICU staff are 
different. If the staff are the same, all ICUs in the hospital 
will be considered a single unit of randomisation. The 
allocation of the initial intervention (ie, FFVM or RFVM) 
will be performed through blocks of different sizes and 
stratified by number of ICU beds. A randomisation list will 
be generated, and ICUs will be consecutively randomised 
as per the date of approval by the local research ethics 
committee. In order to guarantee allocation conceal-
ment, a statistician will receive an identification code for 
each unit but will remain blinded to the identity of the 
ICU. The statistician will then inform the allocation for 
each unit identification code to the research coordinator. 
Lastly, the research coordinator will inform the ICUs 
regarding the group to which they were initially allocated.
blinding
It is not feasible to blind the researchers, patients, family 
members or ICU professionals to the study interventions.
outcomes
Primary outcome
The primary outcome is the cumulative incidence of 
delirium during the ICU stay. Diagnosis of delirium 
will be made using the validated Brazilian translation of 
the CAM-ICU,32 which will be applied at least once per 
12 hours shift in patients with RASS ≥−3, by trained ICU 
professionals. The cumulative incidence of delirium is 
defined as the presence of delirium (at least one positive 
CAM-ICU) on at least one 12-hour shift during the ICU 
stay. Before study initiation, all professionals responsible 
for CAM-ICU assessment will receive training concerning 
the CAM-ICU. This specific training will be given both 
during investigator meetings and on-site. Furthermore, 
inter-rater reliability measurements of the CAM-ICU and 
RASS will be performed before study initiation to eval-
uate the quality of assessments and, if necessary, addi-
tional training will be provided. A sensitivity analysis of 
the primary outcome adjusted for the baseline risk of 
developing delirium determined by the PREdiction of 
DELIRium in ICU patients (PRE-DELIRIC) score33 will 
be conducted to check the consistency of the results. 
There will be three a priori defined subgroup analyses 
for the primary endpoint: (1) effectiveness of FFVM 
versus RFVM in ICUs according to the PRE-DELIRIC 
score (patients with a predicted risk <25%, 25%–50%, 
50%–75% and >75%); (2) effectiveness of FFVM versus 
RFVM in ICUs according to patient group (medical vs 
surgical, and neurocritical vs non-neurocritical); and (3) 
effectiveness of FFVM versus RFVM in ICUs according 
to Acute Physiology and Chronic Health Evaluation 
II (APACHE-II) scores (≤15 vs >15 points). Additional 
exploratory subgroup analysis will be performed based 
on the level of patient’s exposure to sedation, ICU profes-
sional’s workload and proportion of private ICU beds.
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Secondary outcomes
Secondary outcome measures include daily hazard of 
delirium, ventilator-free days, any ICU-acquired infec-
tions (pneumonia or urinary tract infection or blood-
stream infection according to Centers for Disease Control 
and Prevention guidelines34–36), ICU length of stay and 
all-cause hospital mortality among patients; symptoms 
of anxiety and depression measured by the Hospital 
Anxiety and Depression Scale (HADS)37 and satisfaction 
measured by the Critical Care Family Needs Inventory 
(CCFNI)38 among family members; and prevalence of 
symptoms of burnout syndrome measured by the Maslach 
Burnout Inventory (MBI)39 among ICU professionals. 
The daily hazard of delirium will be evaluated using a 
joint modelling approach,40 which is recommended to 
account for days at risk for delirium (ie, ICU days in a 
non-comatose state).
All cases of ICU-acquired infections will be adjudicated 
by an infectious disease physician blinded to the study 
interventions. Family members and ICU professionals will 
be evaluated through self-administered questionnaires.
Tertiary outcomes
Tertiary outcomes will include need for antipsychotic 
agents and/or mechanical restraints, coma-free days, 
unplanned loss of invasive devices and ICU-acquired 
pneumonia, urinary tract infection or bloodstream infec-
tion among ICU patients; self-perception of involvement 
in patient care (ie, reorientation activities, pain control, 
mobilisation, feeding, comfort, emotional support and 
communication (helping patients to interpret ICU staff 
orientations and ICU professionals to understand patient 
needs)) among family members; and satisfaction among 
ICU workers.
Length of ICu intervention, participant recruitment and 
timeline, data collection, management and monitoring
The length of study phases will be determined by the 
patient recruitment rate. During phase 1, 25 patients per 
ICU will be enrolled. After enrolment of the 25th patient, 
a 30-day period without subject recruitment (ie, washout 
period) will occur to allow appropriate conclusion of the 
follow-up of all recruited patients for the study outcomes 
and to avoid contamination of the two study arms. After 
this period, each ICU will be crossed over to the other visi-
tation model (phase 2), with enrolment of an additional 
25 ICU patients per ICU.
The study flow diagram is shown in figure 2, and the 
schedule of enrolment, interventions and assessments 
is shown in online supplementary file 2. Patients and 
Figure 2 Study flow diagram. FFVM, flexible family visitation model; ICUs, intensive care units; ITT, intention-to-treat; RFVM, 
restrictive family visitation model.
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family members will be recruited during phases 1 and 
2. ICU professionals will be evaluated and followed up 
only during the phase 1 in order to avoid the carryover 
effect. Patients will be followed up from study enrolment 
to hospital discharge or death, or a maximum of 30 days. 
Family members will be evaluated at two time points: 
within the first 48 hours of patient inclusion into the 
study (for baseline data) and within 7 days from patient 
discharge from ICU or death, or a maximum of 30 days 
(for outcomes assessment). ICU professionals will be eval-
uated at two time points: 2 weeks before initiation of the 
first randomised ICU intervention (for baseline data) 
and during phase 1 (for outcome assessment).
Trained research personnel at the local sites will 
prospectively collect data on printed case report forms 
that will be entered into an electronic data capture system 
(REDCap, Vanderbilt University, Tennessee, USA).41 In 
order to allow intention-to-treat analyses, data will be 
collected and analysed independent of adherence to 
study interventions. We will deploy the following proce-
dures to enhance the implementation of study interven-
tions and ensure data quality:
1. All local principal investigators and subinvestigators 
will attend an on-site training session before the be-
ginning of the study to standardise procedures includ-
ing data collection.
2. All ICUs will have a learning period within the first 
15 days of phases 1 and 2. During this period, ICUs 
will receive the intervention (FFVM or RFVM) but will 
not recruit subjects. Local investigators will use this 
period to adapt the ICU staff to the organisational 
aspects of study intervention, including rules about 
visiting hours (for both FFVM and RFVM periods), 
guidance to visitors about the minimum require-
ments to promote a safe and restful environment to 
ICU patients (for both FFVM and RFVM periods), 
role of ICU professionals during family visiting hours 
(for FFVM period) and conduction of family mem-
bers-directed structured meetings (for FFVM period). 
Furthermore, local investigators will use this period to 
test the study measurements (CAM-ICU, HADS, CCF-
NI and MBI) and address concerns regarding case re-
port filling.
3. The investigators will be able to contact the coordinat-
ing centre to solve any potential issues or problems.
4. Data cleaning will be applied continuously to identify 
inconsistencies and missing data. The centres will be 
notified of any inconsistencies and missing data and 
prompted to solve them.
5. The coordinating centre will review detailed reports 
on screening, inclusion, follow-up and data consisten-
cy and completeness on a weekly basis. The coordi-
nating centre will take immediate action to solve any 
problems.
6. Centres will be monitored throughout the study. On-
site monitoring visits will occur during phases 1 and 2. 
A trained professional appointed by the coordinating 
centre will perform the monitoring visit. During the 
monitoring visits, all information will be considered 
strictly confidential.
To assess the fidelity and quality of the proposed 
interventions, we will perform on-site monitoring visits, 
with a standardised checklist, in order to evaluate if the 
processes are consistent with the intended intervention 
or if there are important deviation from the proposed 
protocol; perception of effectiveness and barriers for 
implementation will be assessed qualitatively, through 
semistructured interviews with healthcare professionals 
involved in the study.42 In addition, we will collect data 
related to the length of visits for included patients, study 
website access and family members characteristics. A data 
monitoring committee is not required as the risk of study 
interventions causing significant harms is low.
sample size and sampling
A minimum of 33 ICUs with recruitment rate of 50 
patients per ICU (25 patients per study phase) will be 
needed (total of 1650 patients) to detect an absolute 
difference >6.0% in the cumulative incidence of delirium 
between the two study arms (considering an outcome 
incidence rate of 20.5% in the RFVM), with 80% power, 
and two-tailed 0.05 alfa. Two levels of intraclass correla-
tion coefficient (ICC) were considered to calculate the 
sample size: 0.05 for subjects in the same cluster/time 
period and 0.01 for subjects in the same cluster/different 
time periods. Estimates of sample size for the primary 
outcome were made on the basis of the cumulative inci-
dence of delirium found in a single centre before-and-
after study that evaluated the effect of different policies of 
family visitation on the incidence of delirium.12 In order 
to compensate for potential ICU and patient losses, the 
present study plans to recruit 40 ICUs.
statistical analysis
A detailed statistical analysis plan will be prepared before 
data analysis and is intended to be published or made 
available online. All analyses will be conducted with the 
intention-to-treat principle. The comparison of cumu-
lative incidence of delirium will be performed using 
models for correlated data considering the ICU as a 
cluster and presented as risk ratios and 95% CIs. The 
same models will be used for analysis of secondary and 
tertiary outcomes, that is, considering the ICU as a cluster 
and each outcome with its adequate probability distribu-
tion. A statistical significance level of 0.05 will be adopted 
for all statistical comparisons. The R-Development Core 
Team will be used for analysis.
dIsCussIon And trIAL stAtus
Flexible ICU visiting policy is a complex intervention, with 
multiple components, targeting different populations with 
specific outcomes. Figure 3 describes the logic model for 
the FFVM. Although several outcomes are expected to have 
a positive impact, we chose incidence of delirium as primary 
outcome because it combines a strong potential for causal 
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and direct association and an important clinical impact. 
Delirium is a highly prevalent ICU complication and is asso-
ciated with increased mortality, longer ICU and hospital stay, 
higher cost of care and long-term cognitive impairment.43–45 
Therefore, identifying interventions that may reduce the 
risk and burden of delirium in ICU patients is of para-
mount importance to improve healthcare quality. Other 
important outcomes, such as ICU-acquired infections and 
length of stay, levels of burnout among ICU professionals 
and symptoms of anxiety and depression and satisfaction 
among family members may have both a direct and indirect 
relation with the proposed intervention and, therefore, may 
represent important markers of effectiveness and safety of 
the proposed intervention. An FFVM rooted in education of 
family members may reduce the theoretical risk of increase 
in ICU staff workload, disorganisation of care and ICU-ac-
quired infections. The higher access to information may 
have a positive effect on family members’ satisfaction and 
interactions with the patients and ICU professionals. More-
over, an FFVM may result in shorter ICU stay, mediated, for 
instance, by a lower incidence of delirium; additionally, a 
better understanding of the condition by the family may 
avoid delays in ICU discharge.
To the best of our knowledge, this will be the first large-
scale, multicentre randomised trial evaluating the effects 
of different policies of ICU visitation on patients, family 
members and ICU professionals. Results of this study will 
allow healthcare professionals, researchers and police 
makers to draw conclusions about the efficacy and safety 
of a FFVM in adult ICUs.
Our study has some limitations. First, high variability 
across institutions is expected; although the chosen ICCs 
may be considered conservative, there are no estimates in 
the literature for the proposed intervention, which may 
result in lack of power if the actual ICC is larger than the 
estimate. Also, no masking of outcome assessors may result 
in measurement bias for delirium specially with the use of 
an instrument with some degree of subjectivity46; although 
blinding is not feasible for the proposed intervention, in 
order to minimise risk of bias, we chose validated methods 
for delirium evaluation and will make efforts in order to 
standardise data collection through continuing education 
of outcome evaluators. As the number of patients is small 
for each cluster, the estimate time for data collection for 
each study phase is from 2 months to 3 months; this length 
of time may not be enough to properly assess burnout in 
healthcare professionals. Finally, our trial is not designed to 
evaluate long-term outcomes, such as posttraumatic stress 
disorder in patients and family members, as well as micro-
biological changes in ICU flora due to a higher circulation 
of individuals from the community. These issues should be 
assessed in future studies.
The study design and protocol were finalised in March 
2016. All site investigators were required to participate 
in at least one of two investigator meetings (November 
2016 and April 2017). Currently, this study is recruiting 
subjects in 34 ICUs representative of the Brazilian geopo-
litical territory (figure 4). Another six ICUs are in the 
process of preparation for study initiation. We expect that 
this study will be completed in June 2018.
Figure 3 Logic model for flexible ICU visiting hours. FFVM, flexible family visitation model; ICUs, intensive care units; MDR, 
multidrug-resistant; PTSD, posttraumatic stress disorder; RFVM, restrictive family visitation model.
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EthICs And dIssEMInAtIon
Ethics approval and consent to participate
The research ethics committees of all participant institu-
tions approved the study protocol (online supplementary 
file 3). The need for patients’ written informed consent 
was waived in 37 of 40 participating ICUs, because the 
standard of care encompasses both study interventions. 
In 3 of 40 ICUs informed, consent will be required for 
patients or proxies. Informed consent will be required for 
family members and ICU professionals in all ICUs. Site 
investigators will be responsible for obtaining informed 
consent from study participants. Subject confidenti-
ality will be assured through data anonymisation and 
controlled access to case report forms, electronic data 
capture system and datasets. Any breaches of confiden-
tiality, study protocol or adverse events attributable to 
this study will be reported to the above research ethics 
committees.
dissemination
We hope to make the study findings widely available and 
plan to disseminate our results in international confer-
ences and peer-reviewed journals. Authors and collabora-
tors will be involved in reviewing drafts of the manuscripts, 
press releases and any other publication format arising 
from this study.
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